A Study on Oral and Intranasal Forms in Healthy Volunteers using Pharmacokinetic Modeling
This study is for healthy volunteers and aims to understand how a new medicine behaves in the body when given in two different ways: as a tablet (by mouth) and as a nose spray (intranasal). Researchers will be looking at how quickly the medicine gets into the bloodstream, how long it stays there, and how it leaves the body. This kind of research is important in the early stages of developing new medicines, as it helps scientists decide the best way to give the medicine to patients in the future. It's a 'Phase 1' study, meaning it's one of the first times this medicine is being given to people.
At a glance
What is this study about?
Imagine you have a new key, but you're not sure if it works best in the front door or the back door. This study is similar – it's looking at a new medicine and comparing two different ways to give it: one is a tablet or liquid you swallow (by mouth), and the other is a spray that goes into your nose. Scientists want to see which method helps the medicine get into your body and work best.
This type of study is called a 'Pharmacokinetic' study. That's a fancy way of saying we're studying how the body handles the medicine – how it gets absorbed, moves around, is changed by the body, and eventually leaves. Understanding this is really important because it helps doctors and researchers figure out the safest and most effective dose of a medicine, and the best way to give it to someone. It’s like mapping out the journey the medicine takes through your body.
This is a very early stage of research, often called a 'Phase 1' study. It means it's one of the first times the medicine is being tested in people, and the main goal is to check its safety and how it behaves in healthy adults, rather than treating a specific illness. Your participation helps pave the way for potential new medicines that could help many people in the future.
Key takeaways
- Study is for healthy adult volunteers.
- Compares medicine given by mouth and through the nose.
- Aims to understand how the body handles the medicine.
- It's an early-stage or 'Phase 1' study.
- Participation involves health checks and clinic visits.
- Your contribution helps develop future medicines.
Who may be eligible?
This study is looking for healthy adults. You might be able to take part if you are 18 years old or older. There is no upper age limit mentioned, so older adults could also be eligible, as long as they are generally healthy.
Both men and women are welcome to participate in this study. The study focuses on understanding how the medicine works in a broad range of healthy people.
To be considered 'healthy' for a study like this, you would generally need to be free from any long-term medical conditions, not be taking regular prescription medicines, and have normal results on health checks like blood pressure and blood tests. The study team will carry out a full health check to make sure it's safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy with no major ongoing illnesses?
- Are you able to attend clinic visits as required?
- Are you comfortable with blood tests and medical examinations?
- Are you interested in helping with medical research?
What does participation involve?
If you decide to take part, you would first have a screening visit to check your general health and make sure you meet all the study requirements. This might involve blood tests, a physical exam, and answering questions about your health and medical history.
Once enrolled, you would likely have several visits to a clinic. During these visits, you would receive the study medicine, either by mouth or as a nasal spray, depending on which part of the study you are in. Researchers would then take regular blood and urine samples over several hours to see how the medicine is processed by your body. You might also have other checks, like blood pressure and heart rate monitoring.
Some study visits might include an overnight stay or might require you to stay at the clinic for much of the day. The total duration of your participation, including all visits and follow-ups, would be explained to you by the study team, but typically, these early-phase studies can last from a few weeks to a couple of months.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What does 'healthy volunteers' mean?
It means the study is looking for people who generally don't have any major ongoing health conditions or take regular medicines for an illness.
What is a 'Phase 1' study?
This is an early stage of research where a new medicine is tested in people for the first time, mainly to check how safe it is and how the body handles it.
Will I get 'the drug by mouth' and 'intranasal' at the same time?
You would typically receive them at different times, as the study aims to compare how each method works in your body. The study team will explain the schedule.
Will I know if the medicine is working?
This study isn't about treating an illness, so you won't 'feel' it working to make you better. It's about how your body processes the medicine.
Do I get paid to take part?
Many clinical trials offer payment for your time, travel, and inconvenience. The study team will provide details on any compensation.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.